| Investigator |
Institution |
Keywords |
| |
|
|
| Antonella Agrusti
| Università |
brain |
| Paul Aisen
| UCSD |
volumetric analysis |
| Paul Aisen
| Georgetown University |
baseline data |
| Howard Aizenstein
| University of Pittsburgh |
tensor-based morphometry, atlas-based segmentation, classifier algorithms |
| Roman Alberca
| HU Virgen del Rocío |
Alberca |
| Gene Alexander
| Arizona State University |
Voxel-based Morphometry, SPM, Brain Mapping |
| Fabio Almeida
| University of Arizona Medical Center |
optimizing methods PET quantitation |
| Ricardo Alvarez
| Resonancia Magnetica San Jose |
Alzheimer, MRI, Bioengineering, Image Processing |
| shyam anand
| Indian Institute of Technology guwahati |
fMRI analysis |
| Tom Armor
| Certus International |
normal database |
| Steven Arnold
| University of Pennsylvania |
tau, amyloid, age, ethnicity |
| H. Michael Arrighi
| Elan Pharmaceuticals |
progression |
| Gopal Avinash
| GE Healthcare |
ADNI MRI FMRI PET |
| Sukrati Awasthi
| IIITA |
MRI,PET |
| Ulas Bagci
| the university of nottingham |
signal processing, image processing, medical image processing |
| John Baker
| State University of New York at Buffalo |
regression analysis, functional assessment, neuroimaging, neuropsychology |
| Jonathan Bard
| Wyeth Research |
Alzheimer's Disease, Analysis, MRI |
| Steven Barrett
| GlaxoSmithKline |
Data Analysis Methodology |
| George Bartzokis
| UCLA |
structure, intensity, diagnosis |
| Corinna Bauer
| Boston University School of Medicine |
T2 algorithms, MRI manufacturer |
| Laurel Beckett
| UC Davis |
Biostatistics |
| Barry Bedell
| McGill University |
MRI, PET |
| Barry Bedell
| Montreal Neurological Institute |
MRI PET analysis |
| Martin Bednar
| Pfizer Inc |
alzheimer's |
| Duane Beekly
| University of Washington |
NACC |
| Boubakeur Belaroussi
| Bio-Imaging Technologies S.A.S. |
Atrophy Measurement Brain Hippocampus Validation Deformable Registration |
| Luiz carlos Benthien
| Instituto de Neurociencias |
Neurociencias/ Unit neurogeritrics |
| Jay Bergeron
| Pfizer |
Pfizer Clinical Technologies Informatics |
| Charles Bernick
| University of Nevada |
depression, hypertension, diabetes |
| Don Bigler
| Penn State Hershey Medical Center |
Support Vector Machine (SVM), Classifier |
| Ronald Black
| Wyeth Research |
Wyeth clinical research |
| Leo Bleicher
| NA |
segmentation, software |
| Alan Bond
| Institute of Neuroscience, UCLA Medical Center, |
cognitive deficit, system-level, brain model |
| Madhu Boppana
| NYU |
research |
| Lauren Boreta
| Northern California Institute for Research and Education (NCIRE) |
Alzheimer's Disease |
| Michael Borrie
| University of Western Ontario |
Ventricular volume, atrophy, AD, MCI |
| Pierrick Bourgeat
| CSIRO ICT Centre |
Segmentation, registration, longitudinal study |
| Richard Boyes
| Institute of Neurology |
Boundary Shift Integral |
| David Brenner
| University of Alabama at Birmingham |
Dolichoectasia, |
| James Brewer
| University of California, San Diego |
Medial Temporal Lobe, Hippocampus, PET, Morphometry, Volumetrics |
| Jeffrey Browndyke
| Duke University Medical Center |
morphometry precuneus inferior parietal lobule MCI normals |
| Chris Buckley
| GE Healthcare |
MRI, ventricals |
| Cyrill Burger
| PMOD Technologies |
Alzheimer's discrimination, PALZ, pattern analysis |
| Jeffrey Burns
| University of Kansas School of Medicine |
body mass index, diabetes, hippocampal atrophy, whole brain atrophy |
| David Burton
| Alzheimer's Disease Education and Referral Center, the National Insitute on Agin |
n/a |
| PIERO CALVINI
| UNIVERSITA' DI GENOVA |
segmentation of hippocampus, morphometry, Alzheimer's disease early diagnosis |
| Stefan Cano
| Institute of Neurology |
Psychometrics, Rasch analysis |
| Aristides Capizzano
| University of Iowa Hospitals & Clinics |
longitudinal MRI, neurodegeneration, phylogeny |
| Zografos Caramanos
| Montreal Neurological Institute / McGill University |
brain volume, ventricular volume, cortical-grey-matter thickness |
| Jeremy Carmasin
| Massachusetts General Hospital |
PIB FDG AD MCI |
| David Cash
| IXICO Ltd |
huntingtons hdni MR imaging sequence optimization |
| Jesse Cedarbaum
| Elan Pharmaceuticals, Inc |
MCI, biomarker |
| Pierre Celsis
| INSERM |
Cortical thickness, quantitation of brain atrophy |
| Kewei Chen
| Banner Alzheimer Institute |
PET SPM image-derived input function, |
| Howard Chertkow
| Lady Davis Institute for Medical Research |
cortical thickness VBM MCI BA39 BA40 |
| Connie Cheung
| UC Berkeley |
PET, ROI |
| Gloria Chiang
| UCSF |
DTI |
| Jane Chisholm
| Pfizer Inc |
cholesterol, amyloid, burden |
| YIYU CHOU
| UCLA |
AD Ventricle |
| Anette Luther Christensen
| Aalborg University |
atrophy, cerebellum |
| Monica Chu
| UCSD |
hippo volume |
| David Clark
| University of Alabama at Birmingham |
hippocampus, CASL, functional imaging |
| Chris Clark
| University of Pennsylvania |
MCI, AD, Controls, MRI PET |
| Karen-Louise Clemmesen
| Aalborg University |
Alzheimer's, MRI, PET |
| David Clunie
| PixelMed Publishing and RadPharm, Inc |
DICOM compression |
| Alexandre Coimbra
| Merck Research Laboratories |
MRI, automated-segmentation |
| Olivier Colliot
| Université Pierre et Marie Curie - Paris 6 |
classification hippocampus SVM AD MCI |
| Janelle Cooper
| University of Wisconsin - Madison |
T2 hypointensity, globus pallidus, NBIA |
| Paul Coplan
| School of Medicine, University of Pennsylvania |
biomarker, progression |
| Paul Crane
| University of Washington |
AMNART, literacy, age, education, gender |
| Gerald Crans
| Elan Pharmaceuticals |
cognitive tests |
| Ben Cronk
| University of Kansas Medical Center |
Brain Aging Project KUMC |
| Robert Croop
| Bristol-Myers Squibb |
biomarkers |
| Daniel Crowther
| Wyeth |
Training account |
| Charles Curry
| Numenta, Inc. |
statistical learning classification |
| Gina D'Angelo
| University of Pittsburgh |
imaging data, biomarker data, missing data, dimension reduction,prediction tools |
| VITO DOMENICO DAMATO
| AZIENDA OSPEDALIERO-UNIVERSITARIA "OSPEDALI RIUNITI" |
dmtvdm |
| Eveleen Darby
| Baylor College of Medicine |
Alzheimer Disease |
| Christos Davatzikos
| University of Pennsylvania |
classification, MCI, conversion to AD |
| Julie Davidson
| GlaxoSmithKline R&D |
decline, progression, risk factor |
| Geert De Meyer
| INNOGENETICS |
biomarker |
| Giorgio De Nunzio
| University of Salento |
si118ma353 |
| Charles DeCarli
| University of California at Davis |
MRI, cerebrovascular disease |
| Bryan Dechairo
| Pfizer Global Research and Development |
MCI, Genomics, Biomarkers, Imaging |
| Manuel Delfino
| Institut de Fisica d'Altes Energies |
postprocessing |
| Ebrahim Delpassand
| Excel Diagnostic Imaging Clinics |
Teaching, Alheimer's dementia, MCI |
| Douglas Denney
| University of Kansas |
factor analysis, cognition, brain imaging |
| Delphine Dépy Carron
| Calliopae MSC |
cognition cognitive decline |
| Bradford Dickerson
| Massachusetts General Hospital |
MRI, PET, cortical thickness, MCI, AD |
| Ivo Dinov
| UCLA |
Alzheimer's disease, statistics, shape |
| Michael Donohue
| UC San Diego |
ADCS |
| Simon Duchesne
| Université Laval |
Morphometry, MRI, multidimensional analysis |
| Nancy Earl
| GlaxoSmithKline |
decline treatment |
| GOUTHAM EDULA
| ASTRAZENECA R&D |
Image analysis, MRI |
| Ahmet Ekin
| Philips Research |
MR-based markers, longitudinal study |
| GAL ELIDAN
| Stanford University |
VISION, MACHINE LEARNING, AUTOMATIC OUTLINING |
| Simon Eskildsen
| Aalborg University |
cortical thickness, brain mapping, segmentation |
| Francesca Fedele
| INFN-Bari |
registration |
| Howard Feldman
| University of British Columbia |
MRI, brain extraction tools, whole brain volume |
| Christine Fennema-Notestine
| UCSD |
MRI, thickness, morphometry, shape analysis, PET |
| Nikhil Firke
| Pune Institute of Computer Technology |
deformation |
| Anders Fjell
| University of Oslo |
mrophometry, neuropsychology, PET, biomarkers |
| Adam Fleisher
| University of California, San Diego |
ROI, PET, MRI, MCI, Alzheimer |
| Derek Flenniken
| UCSF & VA Medical Center, San Francisco |
CIND |
| Mark Forman
| Merck and Co. |
tau, Abeta, CSF, proteomics |
| Alan Forsythe
| UCLA |
Partition trees, time to event, modified Gehan weights, validation |
| Sabrina Fox-Bosetti
| Merck |
hippocampus |
| Giovanni Frisoni
| IRCCS San Giovanni di Dio FBF - The National Center for Research and Care of Alz |
ADNI EADNI |
| Klaus Fritzsche
| German Cancer Research Center |
validation, evaluation, atrophy estimation, voxel based morphometry |
| Joanna Fueyo
| IBM |
Pattern recognition, text mining, algorithms |
| Yoko Fujimoto
| Pfizer Japan R&D |
Clinical Reserch |
| ken fujiwara
| NCGG |
nilsgo |
| Terence Fullerton
| Pfizer Global Research and Development |
cognition, clinical endpoints, variability |
| Philip Fung
| National institutes of Health |
Biomarkers |
| Anthony Gamst
| University of California, San Diego |
longitudinal data analysis, quasi-likelihood, informatics |
| Christian Gaser
| University of Jena |
classification |
| Gianluca Gemme
| Istituto Nazionale di Fisica Nucleare |
Hippocampus, Segmentation, Atrophy |
| Duncan Gillies
| Impeial College London |
Volume change quantification |
| Michael Gold
| GlaxoSmithKline |
Anomia, stochastics, volumetrics |
| Theresa Good
| University of Maryland Baltimore County |
SERS, ADDL |
| Igor Grachev
| Merck |
PET, MRI |
| Emily Grandey
| Memory Wellness |
Alzheimer's; mild cognitive impairment;cognitive complaint,Parkinson's Disease |
| Barry Greenberg
| Neurochem, Inc. |
biomarker |
| Jeffrey Grethe
| University of California, San Diego |
algorithm, data processing |
| Joan Greve
| Genentech Inc |
AD, PET, MRI, mouse, human |
| Timo Grimmer
| Technische Universitaet Muenchen |
AD, FDG PET, ICA |
| John Grinstead
| Siemens Medical Solutions |
T1 image quality |
| Michael Grundman
| UCSD/Elan Pharmaceuticals |
normal, mci, AD |
| Hongbin Guo
| Arizona State University |
PET, quantification, parametric imaging |
| Jian Han
| Bristol-Myers Squibb Company |
exploratory |
| Tony Han
| Brain Research |
Alzheimer's disease, brain imaging, spm |
| Yousef Hanna
| GE Healthcare |
GE |
| Dawn HARDIN
| NCIRE |
Hippocampus, UCSF, Project Lead, CIND, SNT, Hardin |
| Danielle Harvey
| Unversity of California, Davis |
biostatistics |
| Danielle Harvey
| University of California, Davis |
biostatistics |
| Rolf Heckemann
| Imperial College London |
anatomical segmentation, morphometry, volumetry, |
| Judith Heidebrink
| University of Michigan |
Alzheimer disease |
| Karl Herholz
| University of Manchester |
Alzheimer's disease, Mild cognitive impairment, 18F-FDG-PET |
| Christopher Hess
| UCSF |
neuroradiology, neurodegenerative, diffusion |
| Derek Hill
| IXICO Ltd |
Neurodegeneration trials |
| Derek Hill
| UCL |
artefacts, registration, segmentation |
| Hampus Hillerstrom
| Harvard-MIT Division of Health Sciences & Technology |
trial design Alzheimer mild cognitive impairment |
| Jeremy Hobart
| Peninsula College of Medicine and Dentistry |
Rating scales, psychometrics, reliability, validity, Rasch analysis |
| Robert Hofbauer
| Forest Research Institute |
TBD |
| Daniel Holder
| Merck Research Laboratories |
Biomarkers |
| David Holtzman
| Washington University |
CSF biomarkers |
| Mark Horsfield
| University of Leicester |
software |
| Steven Hou
| Harvard University |
Alzheimer's disease neural networks |
| Fude Huang
| Institute of Neuroscience, Chinese Academy of Sciences |
alzheimer, hippocampus, CA1 |
| Juebin Huang
| Case Western Reserve University |
White Matter |
| Rebecca Hubbard
| University of Washington |
statistical methods |
| Orest Hurko
| University of Dundee |
Medication |
| Stefan Huwer
| Siemens AG |
morphometry, ad |
| Susan Huyck
| Schering Plough |
biomarker |
| Yasuhiko Ikari
| Institute of Biomedical Research and Innnovation |
ikariyasuhiko |
| Fred Immermann
| Wyeth Research |
variability, correlation, regression modeling |
| Michael Irizarry
| GlaxoSmithKline |
ADAS-cog |
| Taro Ishibashi
| The University of Tokyo |
clinical data, biomarker data, imaging data |
| Kenji Ishii
| Tokyo Metropolitan Institute of Gerontology |
PIB FDG PET Japan-ADNI |
| Kaori Ito
| Pfizer Inc |
disease progression |
| Takeshi Iwatsubo
| University of Tokyo |
Japan, J-ADNI |
| Mark Jacobson
| Veterans Affairs San Diego Healthcare |
MRI, morphometry, cognitive profile, MCI |
| Carl Jaffe
| NCI |
data interoperability |
| William Jagust
| UC Berkeley |
PET, ROI |
| Hernan Jara
| Boston University Medical Center |
T2 Q-MRI |
| Radu Jasinschi
| Philips Research |
MRI, structural brain information, data mining |
| Tianzi Jiang
| Institute of Automation, Chinese Academy of Sciences |
Alzheimer's Disease, Cortical Thickness and Complexity, Brain Networks |
| Hans Johnson
| The University of Iowa |
Huntingtons HDNI |
| Sterling Johnson
| University of Wisconsin |
CSF volume, VBM, rates of atrophy |
| David K Johnson
| University of Kansas |
cognition, longitudinal analysis, Alzheimer's disease |
| Sandhya Joshi
| University institute of engineering |
Alzheimer's Parkinson |
| Per Julin
| AstraZeneca |
brain volumetry |
| Kristin Kahle-Wrobleski
| Eli Lilly & Co. |
Alzheimer's disease, functional ability, longitudinal changes |
| David Karow
| ucsd |
PET |
| John Kauwe
| Washington University School of Medicine |
cerebrospinal fluid, amyloid, tau |
| Hirofumi Kawakami
| GE Healthcare |
J-ADNI |
| Andre Khalil
| University of Maine |
White matter, image analysis, wavelet transform, multifractal |
| Iya Khalil
| Gene Network Sciences |
disease causlity, reverse engineering, network inference, biomarkers |
| Neil Killeen
| University of Melbourne |
data management |
| Ron Killiany
| Boston University School of Medicine |
regions of interest, neocortex, hippocampus, entorhinal cortex |
| Tokunori Kimura
| Toshiba Medical Systems |
MR company, qaulity check |
| Richard King
| University of Texas at Dallas |
Morphometric, Volumetric, Atrophy, Dimensionality |
| Justin Kirby
| National Cancer Institute |
n/a |
| DONALD KLEIN
| COLUMBIA UNIVERSITY |
CLINICAL TRIAL POTENTIAL METHODOLOGY |
| Michael Klimas
| Merck |
segmentation, patterns, MRI, PET |
| Juha Koikkalainen
| VTT Technical Research Centre of Finland |
spatial normalization |
| Nickolas Kotran
| Hitachi Medical Systems America |
HMC JADNI |
| Rayhan Lal
| U.C. Berkeley |
PET ROI |
| Susan Landau
| UC Berkeley |
PET FDG ROI |
| Seth Landefeld
| UCSF, SFVAMC |
prognosis, dementia, cognitive impairment, functional decline |
| Jaren Landen
| Pfizer |
Image analysis, MCI conversion to AD |
| Richard Lane
| University of Arizona |
PET ICD amygdala |
| Karen Lau
| Alliant International University |
neuropsychological assessments |
| Richard Leahy
| University of Southern California |
Computational nueroanatomy, cortical analysis, |
| Dongsoo Lee
| Commonwealth Gerontology Institute |
Prevalence, minority, aging |
| Stamatis Lefkimmiatis
| National Technical University of Athens |
image restoration |
| Robert Lenz
| Abbott Labs |
MRI, biomarkers, CSF, PET |
| Alan Lerner
| Case Western reserve University |
hippocampus, apo e, AD |
| Gayle Lester
| National Institutes of Health |
MR Images |
| Allan Levey
| Emory University |
prediction, diagnosis |
| Yi Li
| NYU school of medicine |
FDG-PET PIB-PET MRI |
| Gang Li
| The Methodist Hospital Research Institution |
image analysis |
| Xingfeng Li
| U678 INSERM, CHU Pitié-Salpêtrière |
image processing |
| Lichen Liang
| University of Minnesota |
SVM |
| VINCENZO LIBRI
| GlaxoSithKline |
MRI - PET - |
| Lan Lin
| asu |
AD |
| Lian Liu
| Merck & Co., Inc. |
Alzheimer's Disease |
| Tianming Liu
| Harvard Medical School |
neuroimaging morphmetry |
| Tao Liu
| School of Design, Communication and Information Technology |
MRI;AD;cerebral |
| Veronika Logovinsky
| Eisai Medical Research Inc. |
Bertina, Alzheimer |
| Po-Haong Lu
| UCLA |
Tensor-based morphometry, longitudinal changes, MCI, AD, normal aging |
| James Luo
| NIBIB |
Meta data integration |
| John Lynch
| UCSF |
imaging epidemiology |
| Cindee Madison
| UC Berkeley |
PET ROI |
| Nobuhisa Maeno
| National Institute for Longevity Sciences, NCGG |
AD, amyloid imaging, MRI, cognitive examination |
| Silvio Maglio
| Universita' del Salento |
si118ma353 |
| Ralph Paul Maguire
| Pfizer Global Research & Development |
imaging |
| Joseph Maldjian
| Wake Forest University School of Medicine |
Brain phantom MRI |
| Daniel Marcus
| Washington University School of Medicine |
segmentation, automation |
| Pawel Markiewicz
| The University of Manchester Wolfson Molecular Imaging Centre |
PCA, FDA, FDG PET |
| Gad Marshall
| Brigham and Women's Hospital |
PIB PET, FDG PET, APOE |
| Mara Mather
| University of Southern California |
depression, prefrontal |
| Chester Mathis
| University of Pittsburgh |
PIB |
| Hiroshi Matsuda
| Saitama Medical University |
Alzeheimers Disease, MRI |
| Dawn Matthews
| Abiant, Inc. |
HipMask, PET, Alzheimers, MCI, FTD |
| Mary Pat McAndrews
| University Health Network |
hippocampus, functional imaging |
| Linda McEvoy
| University of California, San Diego |
MRI, PET, morphometry, thickness, prediction |
| Manuel Menéndez
| Hospital Alvarez-Buylla |
MCI, atrophy, early diagnosis |
| Dorit Merhof
| Siemens Molecular Imaging |
statistical evaluation of PET data, anatomical biomarkers of AD disease |
| Roustem Miftahof
| Pohang University of Science and Technology |
none |
| Arthur Mikhno
| Columbia University |
Alzheimers, PET, diagnosis, MRI, voxel |
| Mubeena Mirza
| UCLA |
cortical morphometry |
| Gemma Modinos
| Fundacio ACE |
neuropsychology; movement-cognition correlations; fronto-stratial systems |
| Ananth Mohan
| GE Healthcare |
applications, software solutions |
| Andreas Monsch
| Memory Clinic-Neuropsychology Center |
neuropsychology, clinical, quantitative MRI |
| Bénédicte Mortamet
| CIBM - SIEMENS (leaded by Gunnar Krueger, PhD) |
morphometry |
| Michael Murphy MD, Ph.D
| TorreyPines therapeutics |
clinical research; biostatistics |
| Brian Murray
| Sunnybrook Health Sciences Centre - University of Toronto |
sleep REM sleep behavior disorder alertness |
| Amanda Myers
| University of Miami |
expression, genotype, eQTL, neuropathology |
| Dennis Nelson
| MIMvista Corp |
PET, SPECT, MR, image analysis |
| Kiyotaka Nemoto
| University of Tsukuba Hospital |
VBM |
| Scott Neu
| UCLA |
anatomical point landmark, automation, svd, seed points |
| Art Noda
| Stanford University |
ROC biomarkers |
| Thomas Obisesan
| Howard University Hospital |
cardivascular disease, Alzheimer's disease |
| Lasse Riis Oestergaard
| Aalborg University |
cortical thickness, surface based analysis |
| Joonmi Oh
| Synarc |
Clinical trials |
| John Ollinger
| University of Wisconsin Madison |
dicom python software |
| Salvador Olmos
| Zaragoza University |
morphometry, diffeomorphism |
| Mario Ortega
| UC Davis |
MRI |
| Judy Pa
| University of California, San Francisco |
mild cognitive impairment, neuroimaging |
| Martin Pan
| GlaxoSmithKline R&D |
Clinical progression in AD patients |
| Heath Pardoe
| Brain Research Institute |
VBM, multi-site |
| Ramin Parsey
| Columbia University |
Prediction |
| James Paskavitz
| Perceptive Informatics |
SUV and VBM |
| Maria Pastor
| University of Navarra |
rTMS rehabilitation Parkinson´s disease |
| James Patterson
| LSUHSC - Shreveport |
Alzheimer's disease, PET, MRI, CDI |
| Jon Pauls
| Synarc |
cortical atrophy |
| Guerry Peavy
| UCSD School of Medicine |
hippocampus, stress, cortisol, dementia, Alzheimer's |
| Yahong Peng
| Merch Research Labs |
mixed effects model |
| Jean louis Pepin
| C.H.U.Liège |
electrophysiology, MRI |
| Amy Perkins
| University of Pennsylvania/Philips Research |
PET, MR, fusion |
| Ronald Petersen
| Mayo Clinic |
mild cognitive impairment, Alzheimer's disease |
| Jorge Pezoa
| University of New Mexico |
rician distribution, denoising MRI |
| Mauro Piovezan
| universidade federal do parana - hospital de clínicas |
mauro piovezan |
| Mika Pollari
| Helsinki University of Technology |
registration, cross-sectional and longitudinal analysis |
| Michael Pontecorvo
| Avid Radiopharmaceuticals |
Amyloid, PET, Alzheimer's disease |
| Holly Posner
| Pfizer |
psychometric, Rasch, cognition |
| Steven Potkin
| University of California, Irvine |
Alzheimer's disease, neuropsychological examinations, rate of atrophy |
| Ruolun Qiu
| Pfizer, Inc |
disease progression |
| Constance Dean Qualls
| State University of New York College at Buffalo |
language in aging, cognitive-linguistic aging, dementia |
| V.P.Subramanyam Rallabandi
| National Brain Research Centre |
tissue classification and segmentation |
| Amy Ramage
| University of Texas Health Science Center at San Antonio |
SEM, connectivity |
| Christopher Randolph
| Loyola University Medical Center |
neuropsychology change |
| Richard Raubertas
| Merck & Co. |
data download |
| Debashis Ray
| Apollo Gleneagles Hospital |
NMDA, Memantine,Dopamine |
| Hana Razak
| UiTM |
clinical data for alzheimer's disease |
| William Riddle
| Vanderbilt University |
Deformation Based Morphometry |
| Michele Ries
| University of Wisconsin - Madison |
Mild Cognitive Impairment, MRI |
| Francesco Rinaldi
| IASI |
feature selection; neural networks |
| Matt Rischall
| University of Pittsburgh |
Alzheimer's |
| Lawrence Rodichok
| AstraZeneca Pharmaceuticals |
pharmaceutical trials |
| Michael T. Rogan
| Columbia University |
biomarkers, knowledge management |
| Elizabeth Rogers
| optical BioScience |
alzheimers |
| Ignacio Rojas
| University of Granada |
intelligent system, automatic diagnosis |
| Allyson Rosen
| Stanford University |
aging, MCI, AD |
| Paul Rosenberg
| Johns Hopkins University School of Medicine |
Depression, Alzheimer's, PIB |
| Christopher Rowe
| Austin Health |
PIB, AIBL |
| Prasun Roy
| National Brain Research Center |
MRI, texural analysis, MMSE, CSF, impaired neurogenesis |
| Daniel Rubin
| Stanford Univ |
RDF |
| Daniel Rueckert
| Imperial College |
image registration, morphometry |
| Henry Rusinek
| New York University |
PET, MRI, glucose metabolism, atrophy, regional analysis |
| Laurie Ryan
| National Institute on Aging |
ADNI |
| Ahmed Saad
| Simon Fraser University |
Segmentation, Visualization, 3D+Time |
| Tangaro Sabina
| Istituto Nazionale di Fisica Nucleare - sezione di Bari |
Hippocampus segmentation, co-registration |
| Michael Sachs
| University of Washington |
Data reduction |
| David Salmon
| University of California, San Diego |
learning, recall, recognition |
| Hugh Salter
| AstraZeneca R&D Södertälje |
Genetics |
| Jeffrey Saltzman
| Merck & Company |
Amyloids, Morphology, Tau |
| Vika Samarina
| Stanford/VA Hospital |
WMS-R Logical Memory, memory decline, normal controls, MCI, AD |
| Daniel Saumier
| McGill University |
ADAS-cog, variability |
| Ikuhisa Sawada
| NEDO |
instruction |
| Andrew Saykin
| Indiana University School of Medicine |
MRI, PET, genetics, pattern recognition |
| Douglas Scharre
| Ohio State University |
Screening test |
| Julia Schnabel
| University College London, Centre for Medical Image Computing (CMIC) |
IBIM, shape analysis, modelling, registration, feature detection |
| Lon Schneider
| University of Southern California |
demographics, Alzheimer's disease |
| Craig Schwartz
| UCLA |
brain structure |
| Jeffrey Seeburger
| Merck & Co., Inc. |
Alzheimer's; cognition; biomarker |
| Ravi Seethamraju
| Siemens Medical Solutions |
MR |
| Boran Sekeroglu
| Near East University |
Thresholding, Segmentation |
| Gopalan Sethuraman
| Eli Lilly & Company |
Data Download Training |
| Jeffrey Sevigny
| Merck Research Labs |
cognition, biomarkers |
| Raj Sharma
| VA Hospital Palo Alto |
Pilot data |
| Jaba Sheela
| PEC |
pattern recognition , AD,MRI,classification |
| weijia shen
| National University of Singapore |
medical image segmentation |
| David Shera
| Merck Research Laboratories |
biomarker |
| John Sherman
| Colorado Springs Imaging |
mathematical function, parietal morphometry, Alzheimers |
| Rene Siegel
| Cedars-Sinai Medical Center |
PET, normal |
| Eric Siemers
| Eli Lilly and Company |
biomarkers |
| Margarida Silveira
| Institute for Systems and Robotics / IST |
pattern recognition, machine learning, curse of dimensionality |
| Michael Silver
| New York University |
longitudinal studies, clinical trials, biomarkers |
| Daniel Silverman
| UCLA David Geffen School of Medicine |
Brain, Metabolism, PET, longitudinal, neuropsych |
| Andy Simmons
| Kings College London Institute of Psychiatry |
ADNI AddNeuroMed MMSE ADASCOG |
| Simer Preet Singh
| University of Alabama at Birmingham |
dolichoectasia |
| Saad Sirohey
| GE Healthcare |
Alzheimer 3D-SSP |
| Gary Small
| UCLA |
PET MRI education |
| Stephen Smith
| Oxford University |
MRI AD biomarkers |
| Michael Smith
| CorTechs Labs Inc |
MRI brain volumetric |
| Benjamin Smith
| Simon Fraser University |
segmentation, visualization, kinetic parameters |
| Timothy Smyth
| Northcoast Nuclear Medicine |
PET, fMRI, SPECT, alzheimer's disease, pre treatment, post treatment |
| Sarah Snow
| university of westminster |
AD |
| Peter Snyder
| University of Connecticut |
ApoE, Alzheimer's Disease, Evolutionary Psychology, Pleiotropism |
| Holly Soares
| Pfizer |
Biomarkers |
| Octavian Soldea
| Sabanci University |
Volumetric analysis, structural segmentation of MR and CT images |
| Octavian Soldea
| Sabanci University, Turkey |
volumetrıc segmentation |
| Greg Sorensen
| MGH |
MRI variability |
| Maria Vittoria Spampinato
| MUSC |
VBM, alzheimer, biomarkers |
| Christian Spenger
| Karolinska Institutet |
cortical thickness, B-map |
| Sandro SQUARCIA
| Laboratorio di Fisica e Statistica Medica |
Image fusion, neuroimages, Alzheimer |
| Larry Squire
| University of California, San Diego |
memory |
| Roger Staff
| University of Aberdeen |
Ageing Brain, shape analysis |
| Isaac Stephen
| BU , Graduate Medical Science |
AD, Non-AD - Brain, WM, CSF , T2, DTSE - MRI |
| Yaakov Stern
| Columbia University |
PCA prediction |
| Oliver Strbak
| Institute of Experimental Physics |
iron oxides, MRI, diagnosis, neurodegenerative disease |
| Colin Studholme
| U.C.S.F./VAMC |
Deformation Morphometry |
| Scot Styren
| Pfizer Inc. |
PIB MRI cognition |
| Tetsuhiko Takahasi
| hitachi Medical corporation |
MRI |
| Roger Tam
| The University of British Columbia |
Brain volume change |
| Toshiro Tanaka
| Yokogawa Electic Corporation |
keens |
| Songyuan Tang
| University of North Carolina |
Registration |
| Rajasekhar Tanikella
| University of Alabama at Birmingham |
dolichoectasia |
| Pierre Tariot
| Banner Alzheimer's Institute |
clinical trials |
| Tolga Tasdizen
| University of Utah |
tissue classification |
| Frank Thiele
| Philips Research Labs |
image analysis, FDG-PET, PIB-PET |
| Benjamin Thomas
| University College London Hospital |
FDG, PET, PET-MR, Amyloid |
| Paul Thompson
| UCLA School of Medicine |
MRI, brain, analysis, TBM |
| Lennart Thurfjell
| Uppsala Imanet AB |
PET, MR, diagnsotic featuers, classification |
| MIZUTORI TOSHIYUKI
| Local government employee |
FDG2500 |
| Duygu Tosun
| Laboratory of Neuro Imaging, University of California, Los Angeles |
cortical morphometry, cross-sectional and longitudinal analysis |
| Rochelle E Tractenberg
| Georgetown University School of Medicine |
latent variable analysis; alzheimer's disease, statistical models; tetrad |
| Emily Trittschuh
| Northwestern University, Feinberg School of Medicine |
morphometry - cortical thickness, visual search |
| Gavriil Tsechpenakis
| University of Miami |
image analysis |
| Erman Turan
| Chalmers Biomedical Engineer |
image processing, putamen, globus pallidus |
| Yevgen Tymofyeyev
| Merck & Co., Inc |
biostatistics |
| Tuomas Tölli
| Helsinki University of Technology |
registration, deformation- and voxel-based analysis, classification |
| Kannan Umadevi Venkataraju
| University of Utah |
Brain image analysis |
| Gokhan Uzunbas
| sabanci university |
basal ganglia, segmentation, iron deposition |
| hugo vanderstichele
| Innogenetics |
biomarkers csf plasma |
| Prashanthi Vemuri
| Mayo Clinic Rochester |
MRI |
| Charlotte Videbaek
| H.Lundbeck |
disease progression |
| Javier Villanueva-Meyer
| Baylor College of Medicine |
PET normal volunteers |
| Pieter Jelle Visser
| University of Maastricht |
MCI |
| Maria Vounou
| Imperial College London |
brain images, human genome |
| Kristine B Walhovd
| University of Oslo |
memory, morphometry, PET |
| Sarah Walter
| ADCS |
ADCS |
| Hong Wan
| Wyeth Research |
baseline, decline, rate |
| Alex wang
| lanzhou university |
AD |
| Angela Wang
| University of Utah |
Alzheimer cognitive impairment memory decline MRI PET |
| Lei Wang
| Washington University School of Medicine |
PCA, subfields, deformation |
| Yue Wang
| Merck & Co. Inc |
Merck |
| Yongmei Michelle Wang
| University of Illinois at Urbana-Champaign |
structural and functional brain image analysis |
| Simon Warfield
| Children's Hospital and Harvard Medical School |
mri, image, segmentation, registration |
| Stephen Waring
| Univesity of Texas School of Public Health |
biomarkers, MCI, AD, MRI, hippocampus |
| Alan Waxman
| Cedars-Sinai Medical Center |
Brain PET scan |
| David Webb
| GlaxoSmithKline plc |
epidemiology |
| Michael Weiner
| ucsf |
MRI, PET |
| Michael Weiner
| UCSF/ SFVAMC |
Alzheimer's Disease, Mild Cognitive Decline |
| Fabian Wenzel
| Philips Research |
PET analysis |
| Brandon Whitcher
| GlaxoSmithKline |
GSK |
| Jennifer Whitwell
| Mayo Clinic |
Alzheimer's disease; gradient warping; scaling; rates of atrophy |
| Nana Woerner
| UCSF/SFVA |
AD |
| Andrew Worth
| Neuromorphometrics, Inc. |
brain segmentation, automated segmentation |
| Ying Wu
| Evanston Northwestern Healthcare |
Quantitative analysis, MRI, brain, hippocampus |
| Teresa Wu
| Arizona State University |
PET, data mining, statistical analysis |
| JUN XU
| NANJING MEDICAL UNIVERSITY |
ADNI CHINA |
| Naoko Yamaji
| Micron Inc |
J-ADNI |
| Fumio Yamashita
| University of Tsukuba |
TBM |
| Pingkun Yan
| University of Central Florida |
image segmentation, image registraion |
| Jerome Yesavage
| Stanford University |
Receiver Operator Characterists (ROC) |
| Kai Yuan
| Xi'dian University,China |
fMRI,VBM,DTI,AD |
| Paul Yushkevich
| University of Pennsylvania |
hippocampus, shape, medial, thickness |
| Michael Zagorski
| Case Western Reserve University |
amyloid, NMR |
| Rezi Zawadzki
| Elan Pharmaceuticals |
MRI |
| Scott Zeger
| Johns Hopkins |
Cognitive decline; clinical trial outcome; ADAS Cog; biomarker |
|
